The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship: Is It Worth It?

Erin McElvania TeKippe

Research output: Contribution to journal › Comment/debate

4 Citations (Scopus)

Abstract

Rapid diagnostic testing reduces the turnaround time for pathogen identification in the clinical microbiology laboratory, but the impact on patient care and hospital costs is a matter of speculation. Patel et al. (J. Clin. Microbiol. 55:60-67, 2017, https://doi.org/10.1128/JCM.01452-16) investigate the impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial stewardship to determine if implementation is indeed worth the added costs.

Original languageEnglish (US)
Pages (from-to)20-23
Number of pages4
JournalJournal of Clinical Microbiology
Volume55
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hospital Costs
Microbiology
Mass Spectrometry
Patient Care
Lasers
Costs and Cost Analysis

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship : Is It Worth It? / McElvania TeKippe, Erin.

In: Journal of Clinical Microbiology, Vol. 55, No. 1, 01.01.2017, p. 20-23.

Research output: Contribution to journal › Comment/debate

McElvania TeKippe, E 2017, 'The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship: Is It Worth It?', Journal of Clinical Microbiology, vol. 55, no. 1, pp. 20-23. https://doi.org/10.1128/JCM.02061-16
McElvania TeKippe E. The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship: Is It Worth It? Journal of Clinical Microbiology. 2017 Jan 1;55(1):20-23. https://doi.org/10.1128/JCM.02061-16
McElvania TeKippe, Erin. / The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship : Is It Worth It?. In: Journal of Clinical Microbiology. 2017 ; Vol. 55, No. 1. pp. 20-23.
@article{ba3342ce83eb47fd9fec5d0448e78de4,
title = "The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship: Is It Worth It?",
abstract = "Rapid diagnostic testing reduces the turnaround time for pathogen identification in the clinical microbiology laboratory, but the impact on patient care and hospital costs is a matter of speculation. Patel et al. (J. Clin. Microbiol. 55:60-67, 2017, https://doi.org/10.1128/JCM.01452-16) investigate the impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial stewardship to determine if implementation is indeed worth the added costs.",
author = "{McElvania TeKippe}, Erin",
year = "2017",
month = "1",
day = "1",
doi = "10.1128/JCM.02061-16",
language = "English (US)",
volume = "55",
pages = "20--23",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship

T2 - Is It Worth It?

AU - McElvania TeKippe, Erin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Rapid diagnostic testing reduces the turnaround time for pathogen identification in the clinical microbiology laboratory, but the impact on patient care and hospital costs is a matter of speculation. Patel et al. (J. Clin. Microbiol. 55:60-67, 2017, https://doi.org/10.1128/JCM.01452-16) investigate the impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial stewardship to determine if implementation is indeed worth the added costs.

AB - Rapid diagnostic testing reduces the turnaround time for pathogen identification in the clinical microbiology laboratory, but the impact on patient care and hospital costs is a matter of speculation. Patel et al. (J. Clin. Microbiol. 55:60-67, 2017, https://doi.org/10.1128/JCM.01452-16) investigate the impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial stewardship to determine if implementation is indeed worth the added costs.

UR - http://www.scopus.com/inward/record.url?scp=85027445799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027445799&partnerID=8YFLogxK

U2 - 10.1128/JCM.02061-16

DO - 10.1128/JCM.02061-16

M3 - Comment/debate

C2 - 27847380

AN - SCOPUS:85027445799

VL - 55

SP - 20

EP - 23

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 1

ER -

Access to Document